CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis

Genes and Development

Volumn 12, Issue 18, 1998, Pages 2899-2911

  Franklin, David S ^a   Godfrey, Virginia L ^a   Lee, Hayyoung ^b   Kovalev, Grigoriy I ^a   Schoonhoven, Robert ^a   Chen Kiang, Selina ^b   Su, Lishan ^a   Xiong, Yue ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CDK inhibitors; Gene targeting; Growth regulation; Tumor suppression

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA; PROTEIN P27;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; FEMALE; GENE; GENE TARGETING; GENOTYPE; GROWTH REGULATION; HYPOPHYSIS TUMOR; IMMUNOCHEMISTRY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOUTHERN BLOTTING; T LYMPHOCYTE;

EID: 0032530112     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.18.2899     Document Type: Article

References (37)

1. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
2. Kip1-deficient mice. Cell 85: 733-744.
3. INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell 7: 1587-1599.
4. INK4B/MTS2-related CDK6 inhihitor, correlates with wild-type pRb function. Genes & Dev. 8: 2939-2952.
5. D20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogens 9: 1021-1027.
6. Hunter, T. and J. Pines. 1994. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
7. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
8. Jenkins, C.W. and Y. Xiong. 1995. Immunoprecipitation and immunoblotting in cell cycle studies. In Cell cycle: Material and methods. (ed. M. Pagano) pp. 250-263. Springer-Verlag, New York, NY.
9. Kip1. Cell 85: 721-732.
10. Lee, Y.-H.P., C.-Y. Chang, N. Hu, Y.-C.J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
11. Mathews, L.S., R.E. Hammer, R.R. Behringer, A.J. D'Ercole, G.I. Bell, R.L, Brinster, and R.D. Palmiter. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinol. 123: 2827-2833.
12. Meyerson, M. and E. Harlow. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14: 2077-2086.
13. Morgan, D.O. 1995. Principles of CDK regulation. Nature 374: 131-134.
14. INK4c and IL-6. Immunity 6: 47-56.
15. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.
16. Palmiter, R.D., R.L. Brinster, R.E. Hammer, M.E. Trumbauer, M.G. Rosenfeld, N.C. Birnberg, and R.M. Evans. 1982. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300: 611-615.
17. Pardee, A.B. 1989. G1 events and regulation of cell proliferation. Science 246: 603-608.
18. Phelps, D. and Y. Xiong. 1997. Assay for cyclin D-dependent kinases 4 and 6. Methods Enzymol. 283: 194-205.
19. KIP1. Cell Growth. Differ. 9: 595-610.
20. INK4c's expression during myogenesis. Mol. Cell. Biol. 18: 2334-2343.
21. Quaife, C.J., L.S. Mathews, C.A. Pinkert, R.E. Hammer, R.L. Brinster, and R.D. Palmiter. 1989. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinol. 124: 40-48.
22. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes & Dev. 11: 492-503.
23. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes & Dev. 9: 1831-1845.
24. Robanus Maandag, E.C., M. Van Der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, M. Van Roon, N. Van Der Lugt, A. Berns, and H. Te Riele. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13: 4260-4268.
25. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardos, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37.
26. Sherr, C.J. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
27. _. 1996. Cancer cell cycle. Science 274: 1672-1677.
28. 1 cyclin-dependent kinases. Genes &. Dev. 9: 1149-1163.
29. Su, L., H. Kaneshima, M. Bonyhadi, S. Salimi, D. Kraft, L. Rabin, and J.M. McCune. 1995. HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 2: 25-36.
30. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell 65: 1153-1163.
31. Van Kooten, C. and J. Banchereau. 1997. Function of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9: 330-337.
32. Williams, B.O., E.M. Schmitt, L. Remington, R.T. Bronson, D.M. Albert, R.A. Weinberg, and T. Jacks. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13: 4251-4259.
33. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583.
34. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes & Dev. 11: 973-983.
35. INK4d tumor suppressor protein. Cancer Res. 55: 2503-2506.
36. KIp2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387: 151-158.
37. Zindy, F., H. Soares, K.-H. Herzog, J. Morgan, C.J. Sherr, and M.F. Roussel. 1997. Expression of INK4 inhibitor of cyclin D-dependent kinases during brain development. Cell Growth Differ. 8: 1139-1150.